News
CCT distributable income up 1.6% in 3Q13
Thanks primarily to lower interest expenses.
See what's driving Keppel Corporation's positive outlook
Margins rising, "healthy" rig demand forecasted.
This explains why there won't be panic selling of Singapore homes
Credit Suisse makes a convincing case.
42% of Singaporeans know people having trouble meeting mortgage payments
More will join if interest rates rose.
46% of Singaporeans won't invest in residential property anytime soon
And if they did, they'd want a discount.
No "severe" correction for Singapore property prices: Credit Suisse
Fears exaggerated; expect "flattish" property prices.
Keppel Land acquisitions will focus on residential, 3 other development types
See what the rest are.
Ascendas REIT looks to sponsor's new Business Parks for medium-term growth
As acquisition driven growth mellows.
Google is most attractive employer brand in LinkedIn rankings
Followed by Apple and Unilever.
Electronics exports still the main drag on NODX in September
Don't count on a strong recovery soon.
There's a still market for mass-mid tier homes
But they have to be priced correctly.
A-REIT's performance fee structure could stunt future growth
Possibly limited to between 2-8% growth.
Keppel T&T margin slump could extend till FY14-15
Logistic segment margin looking especially weak.
3 strategic priorities for Singapore SMEs revealed
ACCA Singapore honcho imparts his advice.
Survey shows more Singapore SMEs investing on productivity improvements
To combat rising labour cost.
Singapore SME business confidence steadily improving in past 21 months
Only 29% have had to cut staff.
Read Here
Advertise
Sign Up
Commentary
Green shipping's future: Strategic partnership between public and private finance
The great Singapore family business transition: Why legacy companies are choosing sales over succession
Why SG60 must mark a cybersecurity turning point
What the global financial crisis can teach Singapore about decision-making today
Singapore is ready for EVs, but the industry needs to catch up
Navigating public–private collaboration in Singapore’s health tech and life sciences landscape